FDA's Crawford cleared of affair

An inspector general's probe of a relationship between acting FDA commissioner Lester Crawford and a senior official of the agency concluded that he gave conflicting evidence in the investigation but could not corroborate if he was having an illicit affair. As a result, Republicans moved to push forward with his nomination as commissioner. Investigators said, however, that the unidentified woman told investigators that Crawford had provided improper assistance in gaining a promotion for her, which Crawford denied. Another FDA official contradicted Crawford's statement that he had endorsed the woman for the promotion, saying that he had, in fact, questioned her qualifications.

- read this article from The Washington Post

Suggested Articles

Biotech leaders criticized the dismissals of Chinese scientists from U.S. universities in a letter with more than 150 signatures.

In this week's EuroBiotech Report, Merck allies with Themis on vaccine R&D, Juvenescence raises $100 million and GSK files for anemia approval. 

In our EuroBiotech roundup this week, Scancell withdraws IND, Oxurion’s eye drug fails phase 2a and Abivax starts ulcerative colitis trial.